Virtual Library

Start Your Search

  • WCLC 2015

    16th World Conference on Lung Cancer

    Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado

    Presentation Date(s):  
    • September 6 - 9, 2015
    • Total Presentations: 2499

    To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.

Filter Results:

Show Only Available Presentations

  • +

    YIS - Young Investigator Session incl. Q & A with Longstanding IASLC Members

    • Type: Young Investigator Session
    • Track: Other
    • Presentations: 7
    • Moderators:L. Carr
    • Coordinates: 9/06/2015, 07:30 - 11:00, Mile High Ballroom 4a-4f
    • +

      YIS.07 - Q & A with Longstanding IASLC Members

      10:30 - 11:00  |  Author(s): P.A. Bunn, Jr

      • Abstract

      No abstract available for this presentation

  • +

    P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC

    • Type: Poster
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 87
    • Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P1.01-071 - Long-Term Tolerability Among IRESSA Clinical Access Program (ICAP) Participants in the United States (US)

      09:30 - 09:30  |  Author(s): P.A. Bunn, Jr

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 04 - Clinical Care of Lung Cancer

    • Type: Mini Oral
    • Track: Treatment of Advanced Diseases - NSCLC
    • Presentations: 15
    • Moderators:L. Gaspar
    • Coordinates: 9/07/2015, 16:45 - 18:15, Mile High Ballroom 2c-3c
    • +

      MINI04.08 - Malignant Pleural Effusions Are Predictive of Peritoneal Carcinomatosis in Patients with Advanced EGFR Positive Non-Small Cell Lung Cancer

      17:25 - 17:30  |  Author(s): T. Patil

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 09 - Drug Resistance

    • Type: Mini Oral
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 14
    • Moderators:L. Villaruz
    • Coordinates: 9/07/2015, 16:45 - 18:15, 205+207
    • +

      MINI09.01 - Inhibiting Tankyrase Prevents Epithelial-To-Mesenchymal Transition and Synergizes with EGFR-Inhibition in Wnt-Dependent NSCLC Lines

      16:45 - 16:50  |  Author(s): H.A. Scarborough

      • Abstract

      Loading...

    • +

      MINI09.06 - Oncogenic Drivers including RET and ROS1 plus PTEN Loss and MET by IHC in Patients with Lung Adenocarcinomas: Lung Cancer Mutation Consortium 2.0

      17:15 - 17:20  |  Author(s): B.E. Johnson

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.04 - Poster Session/ Biology, Pathology, and Molecular Testing

    • Type: Poster
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 109
    • Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P2.04-006 - MiRNA Signature to Assess Sensitivity to FGFR Tyrosine Kinase Inhibitors

      09:30 - 09:30  |  Author(s): C.J. Rivard

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      P2.04-007 - In Vitro and in Vivo Efficacy of AZD9291 Is Enhanced by Combination with AZD4547 in EGFR Mutant Lung Cancer Cells

      09:30 - 09:30  |  Author(s): D.C. Chan

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.06 - Poster Session/ Screening and Early Detection

    • Type: Poster
    • Track: Screening and Early Detection
    • Presentations: 29
    • Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P2.06-007 - A miRNA Signature Derived From Independently Replicated Biomarkers of Non-Small Cell Lung Cancer

      09:30 - 09:30  |  Author(s): C.J. Rivard

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    P2.07 - Poster Session/ Small Cell Lung Cancer

    • Type: Poster
    • Track: Small Cell Lung Cancer
    • Presentations: 18
    • Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
    • +

      P2.07-002 - Effects of Eribulin and Radiation on a Panel of Small Cell Lung Cancer (SCLC) Cell Lines

      09:30 - 09:30  |  Author(s): B. Helfrich

      • Abstract
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    MINI 13 - Genetic Alterations and Testing

    • Type: Mini Oral
    • Track: Biology, Pathology, and Molecular Testing
    • Presentations: 15
    • Moderators:Y. Koh
    • Coordinates: 9/08/2015, 10:45 - 12:15, 205+207
  • +

    ORAL 23 - Prevention and Cancer Risk

    • Type: Oral Session
    • Track: Prevention and Tobacco Control
    • Presentations: 8
    • Moderators:N. Hanna
    • Coordinates: 9/08/2015, 10:45 - 12:15, 601+603
  • +

    PRC 04 - Press Conference 4

    • Type: Press Conference
    • Track: Other
    • Presentations: 7
    • Moderators:P.A. Bunn, Jr
    • Coordinates: 9/09/2015, 09:45 - 10:45, 108+110+112
    • +

      Daily Theme: Science Drives Lung Cancer Advances - Dr. David R. Gandara, Professor of Medicine, Division of Hematology/Oncology, Director, Thoracic Oncology Program, Senior Advisor to the Director, UC Davis Comprehensive Cancer Center, Sacramento, California

      09:45 - 09:53  |  Author(s): D.R. Gandara

      • Abstract
      • Presentation

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Abstract – Randomized Phase III Trial of Adjuvant Chemotherapy with or without Bevacizumab in Resected Non-Small Cell Lung Cancer (NSCLC): Results of E1505 - Dr. Heather Wakelee, Associate Professor of Medicine (Oncology) at the Stanford University Medical Center, Stanford, California

      09:53 - 10:01  |  Author(s): H.A. Wakelee

      • Abstract
      • Presentation

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Abstract – Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography (LDCT) Screening Volunteers - Dr. Ugo Pastorino, Director Thoracic Surgery, IRCCS Istituto Nazionale dei Tumori Foundation, Milan, Italy

      10:01 - 10:09  |  Author(s): U. Pastorino

      • Abstract
      • Presentation

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Abstract – Multiregion Whole Exome and Transcriptome Sequencing Defines the Genomic Spectrum of EGFR+ NSCLC and Reveals Novel Mechanisms of TKI Resistance - Dr. Daniel Shao Weng Tan, Consultant, Medical Oncology, National Cancer Centre, Singapore

      10:09 - 10:17  |  Author(s): D.S. Tan

      • Abstract
      • Presentation

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Abstract – A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC): SWOG S0819 - Dr. Roy Herbst, Ensign Professor of Medicine, Professor of Pharmacology, Chief of Medical Oncology, Director, Thoracic Oncology Research Program, Associate Director for Translational Research, Yale Comprehensive Cancer Center, Yale School of Medicine, New Haven, Connecticut

      10:17 - 10:25  |  Author(s): R. Herbst

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Abstract – EGFR IHC and FISH Correlative Analyses (SQUIRE Trial): Necitumumab + Gemcitabine-Cisplatin vs Gemcitabine-Cisplatin in 1st-Line Squamous NSCLC - Dr. Fred R. Hirsch, IASLC CEO, Congress President, Professor of Medicine and Pathology, University of Colorado

      10:25 - 10:33  |  Author(s): F.R. Hirsch

      • Abstract
      • Presentation

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

    • +

      Q&A

      10:33 - 10:45

      • Abstract
      • Presentation

      No abstract available for this presentation

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.